Surgix Healthcare Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 17-06-2024
- Paid Up Capital ₹ 0.63 Cr
as on 17-06-2024
- Company Age 28 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 0.90 Cr
as on 17-06-2024
- Revenue 120.54%
(FY 2021)
- Profit -8474.36%
(FY 2021)
- Ebitda -1417.88%
(FY 2021)
- Net Worth -63.36%
(FY 2021)
- Total Assets -36.66%
(FY 2021)
About Surgix Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 0.63 Cr.
The company currently has active open charges totaling ₹9.00 M.
Vishwanath Ananthakrishnan, Sajjan Konikkra, and Kamlesh Dadheech serve as directors at the Company.
- CIN/LLPIN
U51900MH1996PLC100698
- Company No.
100698
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Jul 1996
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Surgix Healthcare Limited offer?
Surgix Healthcare Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets, Supports & Braces, Cervical Pillows.
Who are the key members and board of directors at Surgix Healthcare?
Board Members(3)
Financial Performance and Corporate Structure Insights of Surgix Healthcare.
Surgix Healthcare Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 120.54% increase. The company also saw a substantial fall in profitability, with a 8474.36% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surgix Healthcare?
In 2021, Surgix Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fortune Medical Imaging Private Limited
Active
2 years 3 months Vishwanath Ananthakrishnan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab & Maharashtra Co-Op. Bank Ltd. Creation Date: 08 Aug 2000 | ₹1.00 M | Open |
Union Bank Of India Creation Date: 19 Jun 1999 | ₹2.00 M | Open |
Union Bank Of India Creation Date: 19 Jun 1999 | ₹5.50 M | Open |
How Many Employees Work at Surgix Healthcare?
Unlock and access historical data on people associated with Surgix Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surgix Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surgix Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
